Face off - The interplay between activating and inhibitory immune receptors

Current Opinion in Immunology

Volumn 13, Issue 3, 2001, Pages 326-331

  Lanier, L L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR;

ALTERNATIVE RNA SPLICING; B LYMPHOCYTE; BONE MARROW CELL; CELLULAR IMMUNITY; EXPRESSED SEQUENCE TAG; GENE LIBRARY; HUMAN; LEUKOCYTE FUNCTION; LIGAND BINDING; NATURAL KILLER CELL; NONHUMAN; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

EID: 0035366156     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(00)00222-3     Document Type: Review

References (81)

1. Lymphocytes with a complex: Adapter proteins in antigen receptor signaling
2. Costimulatory regulation of T cell function
3. Interaction of CTLA-4 with the clathrin-associated protein AP50 results in ligand-independent endocytosis that limits cell surface expression
4. Interaction of CTLA-4 with AP50, a clathrin-coated pit adaptor protein
5. Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4
6. Molecular basis of T cell inactivation by CTLA-4
7. Tyrosine-independent transmission of inhibitory signals by CTLA-4
8. The inhibitory function of CTLA-4 does not require its tyrosine phosphorylation
9. Cytotoxic T lymphocyte antigen-4 (CTLA-4) engagement delivers an inhibitory signal through the membrane-proximal region in the absence of the tyrosine motif in the cytoplasmic tail
10. Stimulation of CD28 triggers an association between CD28 and phosphatidylinositol 3-kinase in Jurkat T cells
11. Binding of phosphatidyl-inositol-3-OH kinase to CD28 is required for T-cell signalling
12. CD28 delivers costimulatory signals independently of its association with phosphatidylinositol 3-kinase
13. Lymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous
14. Phenotypic analysis of CTLA-4 and CD28 expression during transient peptide-induced T cell activation in vivo
15. + regulatory cells that control intestinal inflammation
16. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4
17. + immunoregulatory T cells that control autoimmune diabetes
18. + T cells
19. Lack of a role for TGF-β in CTLA-4 mediated inhibition of T cell activation
20. Molecular cloning of a novel murine cell-surface glycoprotein homologous to killer cell inhibitory receptors
21. A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells
22. Genomic structures and chromosomal location of p91, a novel murine regulatory receptor family
23. Biochemical nature and cellular distribution of the paired immunoglobulin-like receptors, PIR-A and PIR-B
24. Paired immunoglobulin-like receptor (PIR)-A is involved in activating mast cells through its association with Fc receptor γ chain
25. The paired Ig-like receptor PIR-B is an inhibitory receptor that recruits the protein-tyrosine phosphatase SHP-1
26. Inhibitory and stimulatory functions of paired Ig-like receptor (PIR) family in RBL-2H3 cells
27. Constitutive tyrosine phosphorylation of the inhibitory paired Ig-like receptor PIR-B
28. Paired Ig-like receptor homologs in birds and mammals share a common ancestor with mammalian Fc receptors
29. Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: Structural evidence for new stimulatory and inhibitory pathways
30. A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules
31. A new human gene complex encodes the killer cell inhibitory receptors and a related family of monocyte/macrophage receptors
32. Identification of the CD85 antigen as ILT2, an inhibitory MHC class I receptor of the immunoglobulin superfamily
33. Human myeloid cells express an activating ILT receptor (ILT1) that associates with Fc receptor γ-chain
34. Plasticity in the organization and sequences of human KIR/ILT gene families
35. A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involving antigen processing
36. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells
37. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules
38. The MHC class I binding proteins LIR-1 and LIR-2 inhibit Fc receptor-mediated signaling in monocytes
39. The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18
40. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules
41. Crystal structure and ligand binding properties of the D1D2 region of the inhibitory receptor LIR-1 (ILT2)
42. BIT, an immune antigen receptor-like molecule in the brain
43. A novel membrane glycoprotein, SHPS-1, that binds the SH2-domain-containing protein tyrosine phosphatase SHP-2 in response to mitogens and cell adhesion
44. Activation of protein-tyrosine phosphatase SH-PTP2 by a tyrosine-based activation motif of a novel brain molecule
45. A family of proteins that inhibit signalling through tyrosine kinase receptors
46. Mouse and human SHPS-1: Molecular cloning of cDNAs and chromosomal localization of genes
47. High expression of inhibitory receptor SHPS-1 and its association with protein-tyrosine phosphatase SHP-1 in macrophages
48. Identification of major binding proteins and substrates for the SH2-containing protein tyrosine phosphatase SHP-1 in macrophages
49. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM
50. Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome
51. Crystal structures of the XLP protein SAP reveal a class of SH2 domains with extended, phosphotyrosine-independent sequence recognition
52. Negative regulation of growth hormone receptor/JAK2 signaling by signal regulatory protein alpha
53. SH2-B and SIRP: JAK2 binding proteins that modulate the actions of growth hormone
54. Negative regulation of phagocytosis in murine macrophages by the Src kinase family member, Fgr
55. SHPS-1 is a scaffold for assembling distinct adhesion-regulated multi-protein complexes in macrophages
56. Integrin-associated protein is a ligand for the P84 neural adhesion molecule
57. CD47 is a ligand for rat macrophage membrane signal regulatory protein SIRP (OX41) and human SIRPα 1
58. Role of CD47 as a marker of self on red blood cells
59. Epidermal growth factor stimulates the tyrosine phosphorylation of SHPS- 1 and association of SHPS-1 with SHP-2, a SH2 domain-containing protein tyrosine phosphatase
60. Involvement of the Src homology 2-containing tyrosine phosphatase SHP-2 in growth hormone signaling
61. Regulation of early events in integrin signaling by protein tyrosine phosphatase SHP-2
62. Growth hormone regulation of SIRP and SHP-2 tyrosyl phosphorylation and association
63. MFR, a putative receptor mediating the fusion of macrophages
64. Integrin-mediated tyrosine phosphorylation of SHPS-1 and its association with SHP-2. Roles of Fak and Src family kinases
65. Cloning of two members of the SIRPα family of protein tyrosine phosphatase binding proteins in cattle that are expressed on monocytes and a subpopulation of dendritic cells and which mediate binding to CD4 T cells
66. SHPS-1 regulates integrin-mediated cytoskeletal reorganization and cell motility
67. Inhibition of EGFR-mediated phosphoinositide-3-OH kinase (PI3-K) signaling and glioblastoma phenotype by signal-regulatory proteins (SIRPs)
68. Signal-regulatory protein beta 1 is a DAP12-associated activating receptor expressed in myeloid cells
69. Association of signal-regulatory proteins beta with KARAP/DAP-12
70. The ITAM-bearing transmembrane adaptor DAP12 in lymphoid and myeloid cell function
71. Immune inhibitory receptors
72. On guard - Activating NK cell receptors
73. Combined natural killer cell and dendritic cell functional deficiency in KARAP/DAP12 loss-of-function mutant mice
74. DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming
75. Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts
76. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition
77. Molecular basis of HLA-C recognition by p58 natural killer cell inhibitory receptors
78. Kinetics of interaction of HLA-C ligands with natural killer cell inhibitory receptors
79. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E
80. Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors
81. Crystal structure of a lectin-like natural killer cell receptor bound to its MHC class I ligand